Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours

NCT00716417

Conditions: Neoplasms
Locations: 1200.37.3202 Boehringer Ingelheim Investigational Site Brussels, Belgium

1200.37.3201 Boehringer Ingelheim Investigational Site Edegem, Belgium

1200.37.3203 Boehringer Ingelheim Investigational Site Ghent, Belgium

View Trial Details

Completed

Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery

NCT05343260

Conditions: Aged, Anesthesia, Inhalation, Anesthesia, Intravenous, +8 more
Locations: Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital Beijing, Beijing Municipality, China

Beijing Shijitan Hospital Beijing, Beijing Municipality, China

Peking University Cancer Hospital Beijing, Beijing Municipality, China

Cancer Hospital of Guangxi Medical University Nanning, Guangxi, China

View all 15 locations

View Trial Details

Completed

Phase I Trial of BI 836845 for Various Solid Cancer

NCT01403974

Conditions: Neoplasms
Locations: China Medical University Hospital Taichung, Taiwan

NCKUH Tainan, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

NCT01051635

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE

NCT06247865

Conditions: Neoplasms
Locations: Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital Portsmouth, Hampshire, United Kingdom

View Trial Details

Completed

BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

NCT02123823

Conditions: Neoplasms
Locations: Medical University of Graz State Hospital - University Hospital Graz Graz, Austria

Wilhelminenspital Vienna, Austria

Brussels - UNIV UZ Brussel Brussels, Belgium

Brussels - UNIV Saint-Luc Brussels, Belgium

View all 38 locations

View Trial Details

Completed

Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types

NCT01317420

Conditions: Neoplasms
Locations: St James's University Hospital Leeds, United Kingdom

The Royal Marsden Hospital, Sutton Sutton, United Kingdom

View Trial Details

Completed

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3

NCT06926673

Conditions: Neoplasms
Locations: GSK Investigational SIte Nashville, Tennessee, United States

GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Brampton, Ontario, Canada

GSK Investigational Site Toronto, Ontario, Canada

View all 15 locations

View Trial Details

Completed

Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2

NCT01837693

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations: Unità Locale Socio-Sanitaria 17 Este Monselice Este, Italy

Istituto per lo Studio e la Prevenzione Oncologica Florence, Italy

Azienda Sanitaria Locale 2- Regione Umbria Perugia, Italy

Azienda Sanitaria della Provincia Autonoma di Trento Trento, Italy

View Trial Details

Completed

A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001)

NCT03918278

Conditions: Neoplasms
Locations: Henry Ford Health System ( Site 0002) Detroit, Michigan, United States

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0003) Hackensack, New Jersey, United States

Next Oncology ( Site 0001) San Antonio, Texas, United States

Macquarie University ( Site 0033) Macquarie University, New South Wales, Australia

View all 16 locations

View Trial Details